LATEST UPDATES

WEB-TV | Investing

Why Neimeth Pharmaceuticals Plc Plans to Raise N3.67bn Through the Capital Market

Aug 16, 2022   •   by   •   Source: WebTV   •   eye-icon 195 views

This edition of the Market Review features Mr. Mathew Obi Azoji, the Managing Director/Chief Executive Officer of Neimeth Pharmaceuticals Plc, who spoke on “Repositioning the Nigerian Pharmaceutical Industry for Global Competitiveness” with Ottoabasi Abasiekong on Tuesday, August 16th, 2022. 

The conversation covered the following issues:

  1. Impact of the CBN N100bn Pharmaceutical Industry Intervention 
  2. Why Neimeth Is Raising N3.67bn Through the Capital Market 
  3. What Investors Should Expect in terms of ROI 
  4. How the Pharmaceutical Manufacturing Industry is Navigating FX and Logistics Challenges. 
  5. Outlook for the Nigerian Pharmaceutical Industry


Related items.

Get the App

apple-store  play-store

Connect with us


Proshare is a professional practice focused on delivering research and information services to bridge the gap between investors and markets; by delivery on credible, reliable, and timely engagements through the following areas — Impact Research, Market Intelligence, Strategic Advisory, Stakeholder Relations & Digital Media.